Accuray Inc. - ARAY Operatsion marja

Ommaviy kompaniya Accuray Incorporated (ARAY) logotipi

CyberKnife tarmog'ining kengayishi va AI rejalashtirishining joriy etilishi o'sishni rag'batlantirmoqda, bu esa Accuray Incorporated (ARAY) kompaniyasini tenderlarda g'alaba qozonish uchun narxlarni moslashuvchan tarzda sozlashga majbur qilmoqda. Operatsion foyda marjasi ushbu bog'liqlikni aniq namoyish etadi, bunda -0.60 ko'rsatkichi metrikaning miqdorini belgilaydi. Moliyaviy barqarorlik yirik tibbiyot markazlariga robototexnika tizimlarini yetkazib berish orqali yanada mustahkamlanmoqda, kompaniya ushbu tizimlar orqali yuqori aniqlikdagi davolashdan daromad oladi.

ARAY - Accuray Inc Sotuvning operatsion rentabelligi 04.07.2022 - 19.11.2026 oraligʻida

ARAY (accuray.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning umumiy tahlili:Accuray, Inc., ARAY
Accuray Incorporated tayyor mahsulotlari

Accuray Incorporated aniqlikdagi radiatsiya terapiyasi uchun yuqori texnologik robototexnika tizimlarini ishlab chiqishga ixtisoslashgan. Operatsion marja asosiy biznesning samaradorligini o'lchaydi va umumiy tushumda soliqlar hamda foiz majburiyatlarigacha bo'lgan foyda ulushini aks ettiradi. Investor uchun ushbu metrika kompaniyaning AI algoritmlariga yo'naltirilgan R&D investitsiyalarini monetizatsiya qilish qobiliyatining ko'rsatkichi bo'lib xizmat qiladi. GURU.Markets platformasida joriy operatsion marja qiymatini tahlil qilish innovatsion rivojlanish va operatsion daromadlilik o'rtasidagi muvozanatni baholash imkonini beradi. Ushbu ko'rsatkichning tendentsiyasi biznesning bozor kapitalizatsiyasidagi xavflarni yoki o'sish potentsialini ochib beradi.

Raqobatdosh kompaniyalar tahlili

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|SLS (SELLAS Life Sciences Group, Inc.) - Operatsion foyda normasi|Operatsion rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Operatsion rentabellik|TuHURA Biosciences Inc. - Operatsion marja|TARA - Operatsion marja|FATE (Fate Therapeutics) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Aadi Bioscience, Inc.|Sotuvning operatsion marjasi TCRX|Operatsion rentabellik CSBR|Operatsion marja XBIT|Operatsion faoliyat rentabelligi CEL-SCI Corp.|Operatsion rentabellik ostherapies.com OSTX|RADX: Operatsion foyda bo'yicha sotuv rentabelligi|ARTV: Sotuvning operatsion marjasi|ANL (Adlai Nortye) - Operatsion foyda bo'yicha sotuv rentabelligi|Veru (VERU) - Operatsion rentabellik|Sotuvning operatsion marjasi Tempest Therapeutics Inc|Operatsion rentabellik Xilio Therapeutics|Operatsion foyda bo'yicha sotuv rentabelligi RENB (Renovaro Inc.)|Operatsion rentabellik Mural Oncology PLC (MURA)|Operatsion marja Kairos Pharma (KAPA)|Operatsion rentabellik onkuretherapeutics.com OKUR|GDTC: Operatsion foyda bo'yicha sotuv rentabelligi|CRIS: Sotuvning operatsion marjasi|apollomicsinc.com (APLM) - Sotuvning operatsion marjasi|THAR: Operatsion marja|Sotuvning operatsion marjasi Advanced Biomed Inc.|Sotuvning operatsion marjasi GNPX|Operatsion foyda bo'yicha sotuv rentabelligi CLDI (Calidi Biotherapeutics)|Operatsion marja SBFM|Xenetic Biosciences, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Salarius Pharmaceuticals SLRX|Operatsion marja purple-biotech.com PPBT|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja